The differences in the effects of IL-1β, TNF-α, and IL-6 on the OBs’ differentiation could be relevant regarding anti-cytokine therapies, which are commonly used in the treatment of chronic inflammatory diseases such as RA. The gene discussed is TNF; the disease is rheumatoid arthritis.